Development and characterization of a mouse model for Marburg hemorrhagic fever - Test2 - elhamkhani - TriplyDB

Development and characterization of a mouse model for Marburg hemorrhagic fever

Development and characterization of a mouse model for Marburg hemorrhagic fever

http://www.wikidata.org/entity/Q33384111

about

Animal models for Ebola and Marburg virus infections The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo The Role of Cytokines and Chemokines in Filovirus Infection Filoviruses: One of These Things is (not) Like the Other Mouse models for filovirus infections Neglected filoviruses Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus Antiviral activity of a small-molecule inhibitor of filovirus infection A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge.Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.Intrahepatic infiltrating NK and CD8 T cells cause liver cell death in different phases of dengue virus infection The VP40 protein of Marburg virus exhibits impaired budding and increased sensitivity to human tetherin following mouse adaptation DNA vaccines for biodefense.Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.Marburg virus VP40 antagonizes interferon signaling in a species-specific manner.Mechanism of human antibody-mediated neutralization of Marburg virus Advances in virus-like particle vaccines for filoviruses.Clinical aspects of Marburg hemorrhagic fever Filovirus vaccines.Evaluation of perceived threat differences posed by filovirus variants.Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells.A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.Transcriptional Profiling of the Immune Response to Marburg Virus Infection Prospects for immunisation against Marburg and Ebola viruses.Generation and characterization of protective antibodies to Marburg virus.Forty-five years of Marburg virus research.Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease.Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.Discovery of common marburgvirus protective epitopes in a BALB/c mouse model.A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.Correlates of immunity to filovirus infection.Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.Development of experimental and early investigational drugs for the treatment of Ebola virus infections.Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus

P2860

Q21131118-18032B86-EE93-45B3-90D4-0ED45439E099 Q21131393-0C8B4D5A-3B01-44C3-9173-3CCCCFE1196B Q26778003-925A4503-C8F6-4009-B79A-48EC8B29D583 Q26783063-60426E3A-54F3-4EE1-93F9-A568449C3C6F Q27011569-B39A8499-5667-49DC-99DD-3549E0B5D39A Q28383265-76155C70-69E2-48DB-8DF2-F5D6F6C0821E Q33417197-B62E6339-F0B2-4577-A736-A642532F8F14 Q33538454-979E3370-19DD-4B47-9739-13D29B0529BA Q34033322-51C348E6-CFEF-4281-81D0-2D5ED6FB9D41 Q34040052-F6677993-FDA2-47F9-BABF-9AEAC5EF4D7F Q34371001-E327A82F-C980-4057-BFA8-B8E303935F1F Q34438737-48959EC2-47C6-4F08-8102-3E9215875A05 Q34594813-DB9F7FBB-ECFD-4A5E-BAE7-35387B84DF19 Q34614260-6DFFA039-9652-4246-8113-5E3E50159DA0 Q35076563-BB9CF2B0-525B-43D2-8F3B-058385F01F28 Q35076858-D5A64B61-D57B-4958-9C80-68E9BF8494BC Q35132756-C5887D79-83C8-4F24-90C0-6E1D5C498A08 Q35300029-80194392-E34D-44C2-A47C-3B9EB1D5426B Q35446144-125ED4A2-11C3-4351-B21C-04DDBCDC303E Q35558539-1E77C544-FD16-4AA5-ACE7-83CCC927A763 Q35601783-B3A45D5C-BA36-4C48-9E48-40491E3C0B2C Q35675647-6B7C5516-975C-42BC-8A50-6FD438D0F1A0 Q35798489-F7BFA3D6-0C95-49B5-9986-30C681AFFC71 Q36043164-AA35F508-8D88-4460-B8F0-BEF80A23D575 Q36043219-258D179C-7D6D-4716-9910-B27842E8BDBB Q36043232-E316D5A0-8078-4C2F-87D0-2EA239FD42EE Q36043284-B6492273-3DE6-4DA2-A5EB-7C9BA9175262 Q36080864-B34EFB52-39AB-46A2-B7F1-B03DFBA477D5 Q36088118-5480997D-1013-419B-9386-00D5FB21A28B Q36305916-A95126F3-2608-4439-A172-8FDBCF6BC453 Q36395831-289EBC77-AF56-4A00-B769-CB1F50B209FE Q36562881-F3A627FD-56C0-4359-A843-BC22BD5E1D89 Q36893352-C20C5D15-3A6F-4C3D-9F2A-910002195E0A Q37300391-C8376797-22D8-4D7D-A065-798DF785A12B Q37351948-03ECC3B5-ED97-42B6-B0D4-665D475787C0 Q37504760-A1222027-E91E-4C52-81DE-B2952BEE6619 Q37945233-61BDE9F3-3C20-4567-B485-29B557B0FCFF Q37976671-7ABC5807-FA00-413A-9BE3-C71FE4435858 Q38524949-28B3FB8B-3B10-4D31-9258-BA18D301E4DF Q38599899-8762B15E-3F6F-4CBD-9EF0-445BA93DEE9E

P2860

Development and characterization of a mouse model for Marburg hemorrhagic fever

http://www.wikidata.org/entity/Q33384111

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Development and characterization of a mouse model for Marburg hemorrhagic fever

@ast

Development and characterization of a mouse model for Marburg hemorrhagic fever

@en

type

label

Development and characterization of a mouse model for Marburg hemorrhagic fever

@ast

Development and characterization of a mouse model for Marburg hemorrhagic fever

@en

prefLabel

Development and characterization of a mouse model for Marburg hemorrhagic fever

@ast

Development and characterization of a mouse model for Marburg hemorrhagic fever

@en

P1433

Q33384111-721AEE58-3EF4-415E-BB41-5A8B02D3C336

P1476

Q33384111-7B7CF0D6-333D-4435-A970-4E93DC425198

P2093

Q33384111-1172BC4C-7C79-4DEB-A91B-2BAAB6808124

Q33384111-567CB6A7-6C53-4235-AAC2-423C01FAF72C

Q33384111-64F03848-F54D-4C2C-A42E-F5FB23DEC9B9

Q33384111-7994617C-3021-4775-9AE9-7009B0020A5E

Q33384111-8C24E0EF-4162-499C-BD65-B84D2FE68F9D

Q33384111-A73E65B0-6E8D-4442-AAA5-6D0D2DD92C52

Q33384111-B33334D6-7E30-4F45-A9D3-15F290E26467

Q33384111-C15C496F-F72D-47EB-AB4F-79EB06080913

Q33384111-ED0D4375-9E7D-4DB2-859D-B00285D52E13

P2860

Q33384111-06B7DFA3-0DEE-48CB-852F-9A13BD38CA37

Q33384111-099553F2-1928-4112-B58B-54B300155C78

Q33384111-0DBE8543-1873-4B52-A35C-5589A0AB5F45

Q33384111-0FFB405A-1681-49DC-88BF-065E2F0E4924

Q33384111-1167B519-18B2-43D2-A06D-9AD6D7665061

Q33384111-2332A45F-F4C4-4EE1-8878-705A3300C4C0

Q33384111-2927AAA6-5C01-45D2-AE5B-8EAF95139055

Q33384111-2A059C1B-852C-4F4C-84EF-83CE7DBD5BE5

Q33384111-2E1CB6FB-7C2B-4C56-A9CA-281A1E35B006

Q33384111-33C1049B-D22F-404B-B2F5-B9DFE2F8BAE8

P304

Q33384111-36FA6518-CD3A-466C-ABCE-3B898DEB838E

P31

Q33384111-211B2F50-6969-4472-AE8F-E83AF02257E5

P356

Q33384111-0ACAACDD-D1F0-4AD5-B92B-595984A7247B

P433

Q33384111-5238071A-BCFF-4D85-9A38-31BBD61C3782

P478

Q33384111-2D5DFE89-0B60-4B2E-B813-48E9905ECE64

P50

Q33384111-F184D389-341C-4765-8F94-47A619F01288

P577

Q33384111-EB5E2CE8-601A-4F16-BF44-D531530FC724

P698

Q33384111-2D2F008A-7A80-4CE2-93BF-2EA487C49CE7

P932

Q33384111-94225407-189F-4E40-BD12-41BFA74B6611

P356

P1433

Journal of Virology

P1476

Development and characterization of a mouse model for Marburg hemorrhagic fever

@en

P2093

Christine A Mech

http://www.w3.org/2001/XMLSchema#string

D Anthony Alves

http://www.w3.org/2001/XMLSchema#string

Daniel K Reed

http://www.w3.org/2001/XMLSchema#string

Jay Wells

http://www.w3.org/2001/XMLSchema#string

Kelly L Warfield

http://www.w3.org/2001/XMLSchema#string

Loreen Lofts

http://www.w3.org/2001/XMLSchema#string

Meagan T Cooper

http://www.w3.org/2001/XMLSchema#string

Sean A VanTongeren

http://www.w3.org/2001/XMLSchema#string

Steven B Bradfute

http://www.w3.org/2001/XMLSchema#string

P2860

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Crimean-Congo haemorrhagic fever in Kosova : a fatal case report

Molecular determinants of Ebola virus virulence in mice.

Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management.

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure.

Ebola virus: unravelling pathogenesis to combat a deadly disease.

Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.

Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.

Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.

P304

6404-6415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00126-09

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19369350

http://www.w3.org/2001/XMLSchema#string

P932

2698517

http://www.w3.org/2001/XMLSchema#string